If you’ve had a stent placed to open a blocked heart artery, you know the worry that the artery might narrow again. This study looked at how a common blood sugar measure—called HbA1c—related to that risk.
Researchers reviewed records for 6,297 people who had a stent procedure. They focused on how many later developed in-stent restenosis, which is when the artery narrows again inside the stent. About 1,305 people—roughly 21%—were diagnosed with this problem. The study compared people based on their HbA1c levels, but it did not report the exact numbers or show that one level caused more restenosis.
Because this was a retrospective look at medical records, it can only show a link, not prove that blood sugar changes directly cause the artery to narrow again. We don’t have details on follow-up time, other health differences between groups, or safety signals. The full results and confidence intervals aren’t available yet, so we can’t draw firm conclusions about specific HbA1c targets.
